This survey is part of a series of eight country surveys conducted in the context of the People that Deliver Initiative (peoplethatdeliver.org). This global initiative, which brings together the world’s largest organizations, aims to improve health services performance through the professionalizat...ion of logistics managers.
more
This guidance document has been produced by WHO to assist blood services in the development of national plans to respond to any emerging infectious threats to the sufficiency or safety of the blood supply, whether from an existing infectious agent that is changing in incidence and spread, or from a ...newly identified infectious agent. It is intended that this document be followed to guide the national blood service through the process of planning how to respond in a timely, controlled and appropriate way to any specific infectious threat that may subsequently emerge. It is acknowledged that it is not only the blood supply that may be affected by such emerging infectious threats; in those countries undertaking transplantation, the supply of cell, tissues and organs may also be threatened. Increasingly, blood services are taking overall national responsibility for transplantation in their capacity as the organization responsible for the collection, processing, storage and supply of cells, tissues and organs. This approach is both sensible and appropriate, as the overall donor selection and screening processes are the same or very similar. This guidance document can therefore also be used to assist those bodies responsible for the provision of cells, tissues and organs to prepare for an emerging infectious threat.
more
Parasites & Vectors volume 11, Article number: 264 (2018)
Dengue creates a staggering epidemiological and economic burden for endemic countries. Without a specific therapy and with a commercial vaccine that presents some problems relative to its full effectiveness, initiatives to improve vector... control strategies, early disease diagnostics and the development of vaccines and antiviral drugs are priorities. In this study, we present the probable origins of dengue in America and the trajectories of its spread. Overall, dengue diagnostics are costly, making the monitoring of dengue epidemiology more difficult and affecting physicians’ therapeutic decisions regarding dengue patients, especially in developing countries. This review also highlights some recent and important findings regarding dengue in Brazil and the Americas. We also summarize the existing DENV polymerase chain reaction (PCR) diagnostic tests to provide an improved reference since these tests are useful and accurate at discriminating DENV from other flaviviruses that co-circulate in the Americas. Additionally, these DENV PCR assays ensure virus serotyping, enabling epidemiologic monitoring.
more
Le gouvernement du Bénin a engagé le processus de mise en oeuvre du RAMU dans le but d’améliorer l’accessibilité fi nancière des populations à un paquet de base de soins de santé de qualité. Commencées en 2008, la réflexion, la préparation et la mise en oeuvre du RAMU au Bénin ont fa...it émerger des défi s et des questions divers au sein des acteurs impliqués dans le processus. Ces acteurs qui se retrouvent tant aux niveaux international, national et opérationnel, que dans les secteurs gouvernemental, non-gouvernemental et privé sont la cible principale de cette publication.
more
L’accessibilité géographique et financière constante des médicaments essentiels de qualité,
sûrs et efficaces aux populations est un objectif majeur des politiques pharmaceutiques
nationales.
Pour atteindre cet objectif, le Ministère de la Santé du Burkina Faso a mis en place un systèm...e
public d’approvisionnement en médicaments essentiels qui repose sur la Centrale d'Achat des
médicaments essentiels et consommables médicaux (CAMEG) et ses agences commerciales
régionales et sur les dépôts répartiteurs de districts (DRD) avec un système de recouvrement
des coûts des produits pharmaceutiques.
more
Web annex 6: Injectable prostaglandins versus
placebo or no treatment
Evidence to Decision Framework
This manual is addressed to health care providers dealing with Mycobacterium ulcerans disease (Buruli ulcer). The manual aims to achieve a better understanding of the disease, its clinical presentation and its surgical management. The manual is aimed particularly at district health care providers. A... comprehensive protocol, adapted to each form and stage of the disease, is presented together with comments on the levels of resources and capabilities necessary
to shorten the length of treatment, to prevent complications and to minimize undesired sequelae and thus to obtain the best possible outcome for each patient. Some sections include advice relevant to surgeons (e.g. relating to bone infection). However, the level to which particular comments are intended to apply should be clear from the context.
more
The Lancet Microbe Series Chagas Disease 2 Volume 5, Issue 10100946 October 2024
The Lancet Regional Health - Americas 2024;36: 100821 https://doi.org/10.1016/j.lana.2024.100821
Politique et plan stratégique intégré de lutte contre les maladies non transmissibles (PSIMNT) 2012-2015
Web annex 5: Oxytocin and ergometrine versus placebo or no treatment
Evidence to decision framework
March 2021
This report presents the key findings of the NFHS-5 survey in the National Capital Territory (NCT) of Delhi, followed by detailed tables and an appendix on sampling errors. The 2019-21 National Family Health Survey (NFHS-5), the fifth in the NFHS series, provides information on populatio...n, health, and nutrition for India and each state and union territory.
more